Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced its third annual CoolMonth featuring CoolSculpting® Elite. The celebration is an opportunity for consumers interested in body contouring ...

IRVINE, Calif., Jan. 7, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced its third annual CoolMonth featuring CoolSculpting® Elite. The celebration is an ...

Medical-device maker Stryker on Monday agreed to acquire Inari Medical , which makes devices that treat patients with venous ...

In 1967, Allergan acquired a 24-acre industrial site from the Irvine Company and built a new 100,000-square ... In 2020, it was acquired by AbbVie, which has been a good parent by investing in ...

Irvine, California-based Inari ... pullback 10:53 PM UTC · Updated ago Healthcare & Pharmaceuticalscategory AbbVie cuts 2024 profit forecast on acquisition expenses 10:46 PM UTC · Updated ...

While very early, the results are encouraging, according to Ray Wang, a specialist in metabolic disorders at the University of California, Irvine ... licensing deal with AbbVie for an AAV8 ...

Irvine, CA, USA Pimavanserin is a selective inverse agonist–antagonist of the 5-HT2A receptor that is approved in the USA for treatment of hallucinations and delusions in Parkinson's disease. 1 ...

It's encouraging to see that AbbVie has been growing its earnings per share at 5.7% a year over the past five years. While EPS is growing at a decent rate, but future growth could be limited by ...

Gene therapy firm Capsida Biotherapeutics is advancing the first of its AbbVie-partnered neurodegenerative disease therapies after the Big Pharma exercised a $40 million option for the program.

In its latest attempt to bulk up its cancer drug portfolio, AbbVie has signed a new licensing agreement with China-based Simcere Zaiming to develop a treatment for myeloma, a type of blood cancer ...

AbbVie, with a market cap of over $300 billion, shows strong cash flow potential despite patent expirations, making it a valuable investment. The company reported strong 3Q financials, with ...